About Babson Diagnostics
Babson Diagnostics is a Healthcare company based in Austin (United States) founded in 2017 by Eric Olson. Blood testing services are offered using finger-prick microsamples. Babson Diagnostics has raised $37.7 million across 2 funding rounds from investors including Siemens Healthineers, Emerald and Prism Venture Partners. Its chief executive, as recorded, is David Stein. Babson Diagnostics offers products and services including BetterWay Blood Testing. Its focus areas include Life Sciences, Hematology, In Vitro Diagnostics Tests and Blood Collection Device. Its competitors include Tasso, YourBio Health and Velano Vascular; 3 of its 3 listed competitors have raised funding.
Company details
Provider of blood testing service using microsamples collected from a finger. It offers blood testing services, utilizing small blood samples obtained via finger-prick, aiming to make diagnostic testing more accessible. The offering focuses on delivering medically accurate results through a patient-centric approach. The goal is to facilitate regular diagnostic blood testing for early disease detection and informed healthcare decisions.
- Total Equity Funding$37.7M (USD)
in 2 rounds
- Latest Funding Round$31M (USD), Series B
Jun 2021
- InvestorsSiemens Healthineers
& 4 more
Products & Services of Babson Diagnostics
Babson Diagnostics offers a comprehensive portfolio of products and services, including BetterWay Blood Testing.
Offers convenient blood testing with minimal sample for accurate results.
Apps and channels of Babson Diagnostics
its YouTube channel Babson Diagnostics & BetterWay has 21 subscribers and 4 videos.
Videos from Babson Diagnostics
The most watched videos on Babson Diagnostics's YouTube channel, Babson Diagnostics & BetterWay (21 subscribers). Click a video to play it here.
More on Babson Diagnostics & BetterWay.
Funding Insights of Babson Diagnostics
Babson Diagnostics has successfully raised a total of $37.7M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $31 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $37.7M
- Total Rounds 2
- Last Round Series B — $31M
- First Round $6.7M
(Sep 2020)
- Investors Count 5
All 2 funding rounds of Babson Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2021 | $31M | Series B | – | Emerald Development Managers | |
| Sep 2020 | $6.7M | Series A | – | Genesis Merchant Capital, Siemens Healthineers | – |
5 investors in total: 5 institutional.
Investors in Babson Diagnostics
Babson Diagnostics has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Siemens Healthineers, Emerald and Prism Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage venture capital investments are provided by Emerald. | emeraldmanagers.com | New York, United States | ||
VC firm investing in the US | prismventure.com | Westwood, United States | ||
| genesismerchantcapital.com | ||||
AI-based medical diagnostics are developed for healthcare applications. | 1847 | siemens-healthineers.com | Erlangen, Germany | |
LAGO Consulting & Services is engaged in water resources management and environmental solutions. | lago-consulting.com | Tampa, United States |
Investor details for Babson Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Babson Diagnostics
21 people are tracked at Babson Diagnostics (10 in leadership, 8 in board & advisors, 3 in team).
| Name | Role | Group |
|---|---|---|
Eric Olson | Founder & COO | Leadership |
David Stein | CEO | Leadership |
Roy Barr | VP, Research & Development | Leadership |
Christopher DiPasquale | Vice President Of Assay Development | Leadership |
Jim W. Jacobson | VP, Clinical Affairs | Leadership |
Heath Marr | Director of Laboratory Operations | Leadership |
Misty Mogford | Director, People Operations And HR | Leadership |
Jane H | Director, Quality Assurance & Regulatory Affairs | Leadership |
Chris Tanzi | VP, Product Management | Leadership |
Kimberly Wilson | Sr. Director, Clinical Marketing | Leadership |
Judson Cooper | Director | Board & advisors |
Maninder Kahlon | Advisor | Board & advisors |
Alan Wu | Scientific Advisory Board Member | Board & advisors |
Susan A. Evans | Scientific Advisory Board Member | Board & advisors |
Robert H. Christenson | Scientific Advisory Board Member | Board & advisors |
Dennis Gilbert | Director | Board & advisors |
Cy Schroeder | Board Observer | Board & advisors |
Neil Cohen | Director | Board & advisors |
Hattie McKenzie | Scientist | Team |
Saib Husain | Program Manager | Team |
1 more people are available in the full profile.
Complete people profiles for Babson Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Babson Diagnostics
3 dated milestones of Babson Diagnostics across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Babson Diagnostics is founded.
- Funding First funding round of $6.7M.
- Funding Latest funding round, Series B, of $31.0M.
Competitors of Babson Diagnostics
Babson Diagnostics has 3 listed competitors in our database, 3 of them funded. They include Tasso, YourBio Health and Velano Vascular.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| tassoinc.com | 2014 | Seattle, United States | $123.22M | 1 | Blood collection devices for diagnostic applications are developed. | |
| yourbiohealth.com | 2007 | Medford, United States | $102.23M | 32 | Push-button blood collection devices are manufactured for medical use. | |
| velanovascular.com | 2012 | San Francisco, United States | $51.05M | 19 | Provider of a needle-free blood collection device |
Detailed competitors of Babson Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Babson Diagnostics
The website of Babson Diagnostics (babsondx.com) receives about 1.5K visits a month.
- Monthly visits1.5K
▼ 68.6% vs previous month
Top companies in Hematology
3 companies that operate in the same segment as Babson Diagnostics (Hematology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Catheter-based thrombectomy devices for vascular emboli removal are developed. | 2011 | Irvine, California, United States | USD 51.89 M | USD 493.63 M | 696 | |
Small molecules are developed to treat hematologic and musculoskeletal disorders. | 2016 | Lexington, Kentucky, United States | USD 90 M | USD 244.06 M | 169 | |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders | 2016 | Menlo Park, California, United States | USD 300 M | 384 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Babson Diagnostics
Complete news archive for Babson Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Babson Diagnostics
Babson Diagnostics was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Babson Diagnostics is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
David Stein is the CEO of Babson Diagnostics, as recorded in our data.
Babson Diagnostics is a funded company, having raised a total of $37.7M across 2 funding rounds to date. The company's 1st funding round was a Series A of $6.7M, raised on Sep 2020.
Provider of blood testing service using microsamples collected from a finger. It offers blood testing services, utilizing small blood samples obtained via finger-prick, aiming to make diagnostic testing more accessible. The offering focuses on delivering medically accurate results through a patient-centric approach. The goal is to facilitate regular diagnostic blood testing for early disease detection and informed healthcare decisions.
Babson Diagnostics's top competitors include YourBio Health, Tasso and Velano Vascular.
Babson Diagnostics offers BetterWay Blood Testing.
Babson Diagnostics has 5 investors. Key investors include Siemens Healthineers, Emerald, Prism Venture Partners, LAGO Consulting & Services, and Genesis Merchant Capital.